Study finds 100 million cases of childhood disease prevented thanks to vaccines
PITTSBURGH — Vaccines have prevented an estimated 100 million cases of serious childhood contagious diseases in the nearly 90 years since the vaccine for pertussis, or whooping cough, became available, according to a new study.
The study, conducted by researchers at the University of Pittsburgh Graduate School of Public Health and published in the New England Journal of Medicine, examined weekly surveillance reports for reportable diseases going back to 1888. The researchers focused on eight vaccine-preventable diseases: smallpox, polio, measles, rubella, mumps, hepatitis A, diphtheria and pertussis, overlaying public health data on disease outbreaks on the years that vaccines received regulatory approval and comparing the results from before and after their availability.
The researchers also noted, however, that despite the availability of a pertussis vaccine since the 1920s, the United States last year had its largest pertussis epidemic since 1959, and outbreaks of measles, mumps and rubella have reoccurred since the early 1980s.
With subway mural shopping experience, Jean Coutu Group helps blur lines between retail box and online retailing
Canada’s Jean Coutu Group is helping to bolster holiday sales with the launch of its "e-store window" inside the Longueuil Metro Station. Commuters will be able to shop a wall of deals using their smartphones with delivery before Dec. 24.
It’s not really an example of thinking outside the box, as much as it’s eliminating the concept of a box altogether. It’s an extension of the Jean Coutu brand name into a space typically associated with billboard-style advertising, only stoppers-by can shop the space as easily as they do in the store or online.
It’s reminiscent of Peapod Markets, partnered with Ahold USA supermarket banners, the grocery retailer donning the walls of key public transit hubs across Chicago, New York, Philadelphia and Washington and generally statewide in Connecticut and Rhode Island. That service routinely delivers packages to more than 350,000 customers per year with an average basket size of $157 and "trips," or shopping occasions, typically happening twice per month per regular shopper.
Giant Food Stores of Carlisle, Pa., just last week launched its pickup service at five stores in Pennsylvania’s Montgomery and Bucks counties.
But they’re not the only companies who recently have extended their brand names beyond the traditional retail box.
L’Oréal Paris placed an "intelligent vending experience" within the Bryant Park subway station earlier in November. The smart kiosk first detects the colors in a woman’s outfit and picks out the most prominent and related color palettes, then recommends L’Oréal Paris products to match and allows women to purchase those products on the spot, quickly and easily. The pop-up kiosk will be available through Dec. 30.
A few suppliers are even extending their brand names into complementary retail channels with pop-up shop locations. For example, Red Carpet Manicure, which makes an at-home LED gel manicure system, has set up a Holiday Pop-Up Shop at the trend-setting emporium of fashion, accessory and beauty brands, otherwise known as Henri Bendel’s flagship store on Fifth Avenue in New York City.
Coram acquisition is in line with CVS Caremark’s strategy
CVS Caremark is looking to acquire Coram, the specialty infusion services and enteral nutrition business unit of Apria Healthcare Group, for roughly $2.1 billion. Coram provides infusion therapies and nutrition services to more than 20,000 patients each month.
The acquisition is a significant move for CVS Caremark given the growth of the home infusion business and specialty pharmacy. Furthermore, it enables CVS Caremark to further leverage its “integration sweet spots” and is in line with the company’s strategy of investing in core businesses that will help drive growth.
The infusion services market is estimated to be around $11 billion and the acquisition will undoubtedly enable CVS Caremark to compete in the growing market as specialty infusion drugs account for a significant portion of new drugs in the pipeline.
CVS Caremark executives have long expressed the company’s commitment to expanding its role in specialty pharmacy. Specialty currently represents about 20% of the total drug spend today, but that number is projected to rise to more to than 30% by the end of the decade.
As the company has stated, this move enables CVS Caremark to be a full-service specialty provider and helps the retailer bring new approaches to market that improve the management of specialty pharmacy costs that are covered through the medical or pharmacy benefit, depending on the site of care.